Inso Bio (formerly Tico Bio) is an early-stage biotech startup from Cornell University developing platform technologies for biological sample processing. We are using our patented microfluidic technology to transform the landscape of cellular sample processing, and we are exploring applications in long-read DNA sequencing, multi-omic analysis, and pathogen isolation.
Location: United States, New York, Ithaca
Member count: 1-10
Total raised: $3.205M
Investors 2
| Date | Name | Website |
| 08.07.2022 | Creative D... | creativede... |
| 30.08.2022 | Kevin M. M... | mcgovernce... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 18.04.2022 | Grant | $955K | - | - |
| 30.03.2022 | Pre-Seed | $2.2M | - | - |
| 27.05.2021 | Grant | $50K | - | - |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 01.10.2021 | Here’s all... | Most big accelerators tend to ... | accelerato... | Greg Kumpa... | techcrunch... |